Cargando…
S313: HEALTH ECONOMIC EVALUATION OF THIRD-LINE INTERVENTIONS FOR TRANSPLANT-INELIGIBLE RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN GERMANY
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428336/ http://dx.doi.org/10.1097/01.HS9.0000968164.63952.98 |
| _version_ | 1785090444156207104 |
|---|---|
| author | Sophie Kurte, Melina Siefen, Ann-Cathrine Marie Bauer, Anna Christian Reinhardt, Hans Kron, Florian |
| author_facet | Sophie Kurte, Melina Siefen, Ann-Cathrine Marie Bauer, Anna Christian Reinhardt, Hans Kron, Florian |
| author_sort | Sophie Kurte, Melina |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428336 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104283362023-08-17 S313: HEALTH ECONOMIC EVALUATION OF THIRD-LINE INTERVENTIONS FOR TRANSPLANT-INELIGIBLE RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN GERMANY Sophie Kurte, Melina Siefen, Ann-Cathrine Marie Bauer, Anna Christian Reinhardt, Hans Kron, Florian Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428336/ http://dx.doi.org/10.1097/01.HS9.0000968164.63952.98 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Sophie Kurte, Melina Siefen, Ann-Cathrine Marie Bauer, Anna Christian Reinhardt, Hans Kron, Florian S313: HEALTH ECONOMIC EVALUATION OF THIRD-LINE INTERVENTIONS FOR TRANSPLANT-INELIGIBLE RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN GERMANY |
| title | S313: HEALTH ECONOMIC EVALUATION OF THIRD-LINE INTERVENTIONS FOR TRANSPLANT-INELIGIBLE RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN GERMANY |
| title_full | S313: HEALTH ECONOMIC EVALUATION OF THIRD-LINE INTERVENTIONS FOR TRANSPLANT-INELIGIBLE RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN GERMANY |
| title_fullStr | S313: HEALTH ECONOMIC EVALUATION OF THIRD-LINE INTERVENTIONS FOR TRANSPLANT-INELIGIBLE RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN GERMANY |
| title_full_unstemmed | S313: HEALTH ECONOMIC EVALUATION OF THIRD-LINE INTERVENTIONS FOR TRANSPLANT-INELIGIBLE RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN GERMANY |
| title_short | S313: HEALTH ECONOMIC EVALUATION OF THIRD-LINE INTERVENTIONS FOR TRANSPLANT-INELIGIBLE RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN GERMANY |
| title_sort | s313: health economic evaluation of third-line interventions for transplant-ineligible relapsed or refractory diffuse large b-cell lymphoma in germany |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428336/ http://dx.doi.org/10.1097/01.HS9.0000968164.63952.98 |
| work_keys_str_mv | AT sophiekurtemelina s313healtheconomicevaluationofthirdlineinterventionsfortransplantineligiblerelapsedorrefractorydiffuselargebcelllymphomaingermany AT siefenanncathrine s313healtheconomicevaluationofthirdlineinterventionsfortransplantineligiblerelapsedorrefractorydiffuselargebcelllymphomaingermany AT mariebaueranna s313healtheconomicevaluationofthirdlineinterventionsfortransplantineligiblerelapsedorrefractorydiffuselargebcelllymphomaingermany AT christianreinhardthans s313healtheconomicevaluationofthirdlineinterventionsfortransplantineligiblerelapsedorrefractorydiffuselargebcelllymphomaingermany AT kronflorian s313healtheconomicevaluationofthirdlineinterventionsfortransplantineligiblerelapsedorrefractorydiffuselargebcelllymphomaingermany |